Skip to main content
. 2021 Jul 2;25(6):1573–1580. doi: 10.1007/s10029-021-02449-x

Table 1.

Pre-operative demographics of patients and hernia characteristics

N = 1536 ACS N = 1193 PCS N = 343 P
Demographics and comorbidities
 Age, years, median (IQR) 64.0 (55.0–71.0) 64.0 (54.0–72.0) 64.0 (55.0–70.0) 0.972
 Age > 70 years, N (%) 480 (31.3) 383 (32.1) 97 (28.3) 0.178
 Sex female, N (%) 699 (45.5) 552 (46.3) 147 (43.0) 0.282
 BMI, kg/m2 median (IQR) 29.7 (26.5–33.5) 29.7 (26.6–33.5) 29.4 (26.3–33.3) 0.399
 BMI > 30 kg/m2 (obesity), N (%) 747 (48.7) 586 (49.2) 161 (46.9) 0.452
 BMI > 35 kg/m2 (severe obesity), N (%) 293 (19.1) 229 (19.2) 64 (18.7) 0.808
 Alcohol abuse, N (%) 204 (13.3) 159 (13.3) 45 (13.1) 0.920
 Smoking N (%) 403 (26.2) 324 (27.2) 79 (23.0) 0.126
 AHT, N (%) 791(51.5) 633 (53.3) 158 (46.1) 0.022
 Diabetes mellitus, N (%) 336 (21.9) 268 (22.5) 68 (19.8) 0.297
 COPD, N (%) 277 (18.0) 227 (19.8) 50 (14.6) 0.059
 CRF, N = 657 (%) 65 (9.9) 30 (8.9) 35 (11.0) 0.368
 Immunosuppression N = 524 (%) 79 (15.1) 69 (15.8) 10 (11.4) 0.286
 Oncologic history, N (%) 411 (26.8) 324 (27.2) 87 (25.4) 0.508
 AAA, N = 524 (%) 8 (1.5) 6 (1.4) 2 (2.3) 0.532
 ASA III–IV, N (%) 502 (32.7) 405 (34.0) 97 (28.4) 0.050
Hernia characteristics
 Location
  Midline, N (%) 1349 (87.8) 1071 (89.8) 278 (81.0)  < 0.0001
  Trocar, N (%) 55 (3.6) 29 (2.4) 26 (7.6)  < 0.0001
  Ostomy, N (%) 65 (4.2) 39 (3.3) 26 (7.6)  < 0.0001
  Other, N (%) 71 (4.6) 67 (5.6) 4 (1.2) 0.001
Defect size*
 Area, cm2 (SD) 176,9 (140.7) 187.7 (140.2) 148.7 (138.1)  < 0.0001
 Transverse > 10 cm, (W3) N (%) 822 (65.9) 642 (71.0) 180 (52.5)  < 0.0001
 Longitudinal > 10 cm, N (%) 965 (77.4) 748 (82.7) 217 (63.3)  < 0.0001
 Previous repair, N (%) 486 (31.6) 357 (29.9) 214 (37.6) 0.007
 Previous mesh, N (%) 452 (93.0) 326 (91.3) 126 (97.7) 0.015
Classification of complexity**
 Minor, N (%) 233 (15.2) 175 (14.7) 58 (16.9)
 Moderate, N (%) 577 (37.6) 447 (37.5) 130 (37.9)
 Major, N (%) 726 (47.2) 571 (47.9) 155 (45.2)
Pre-operative treatment
 Pneumoperitoneum, N (%) 73 (4.8) 60 (5.0) 13 (3.8) 0.342
 Botulinum toxin, N (%) 78 (5.1) 34 (2.8) 44 (12.8)  < 0.0001

BMI body mass index, AHT arterial hypertension, COPD chronic obstructive pulmonary disease, CRF chronic renal failure, AAA abdominal aortic aneurysm, ASA American Society of Anaesthesiologists physical status classification

*EHS classification; **Slater NJ et al. [16]